AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
DOXORUBICIN PHARMACOKINETICS - THE EFFECT OF ABNORMAL LIVER BIOCHEMISTRY TESTS
Authors: TWELVES CJ DOBBS NA GILLIES HC JAMES CA RUBENS RD HARPER PG
Citation: Cj. Twelves et al., DOXORUBICIN PHARMACOKINETICS - THE EFFECT OF ABNORMAL LIVER BIOCHEMISTRY TESTS, Cancer chemotherapy and pharmacology, 42(3), 1998, pp. 229-234
ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER
Authors: PARMAR MKB TORRI V BONAVENTURA A BONAZZI C COLOMBO N DELALOYE JF MARSONI S MANGIONI C SANDERCOCK J SESSA C WILLIAMS C TINAZZI A FLANN M GEISER K SCORPIGLIONE N STEWART JF CHAVES J PALMEIRO E CURTAIN A MCCORMACK T GENNATAS C MARRAS F OPPO TG BALESTRINO M MALZONI C MALZONI M BELLI M GEMINIANI ML CRESTANI G MONACO A VAVALA V PIATTO E BARATTINI G FORNARA PG CHETRI MC SANTEUFEMIA G ARTIOLI F CARONE D FANIZZA G TRENTADUE R PRIOLO D SCOLLO P NIGRO SC PETRINA M MASTRANTONIO P SPANNA GD ZAGNI R BELLONI C COLLEONI R REDAELLI L CAVAGNINI A DICOSTANZO G PERRONI D ARIENTI S ORFANOTTI G CANTONI FM SECLI R BIANCHI A MARTINELLO R MOLLICA G MAIZZI D PICCHIARELLI ME FIORINI G BORSANI M COLOMBO E GARSIA S MELGRATI L PAGGI G BRUNENGHI GM CASINI M ISA L ALGERI R PROZIO G BELFIORE G ANGELINI F DAPRILE M MORESCHI M MAURI ML NATALE N SENZANI FM PAVANATO G POGGI G GARUTI G LUERTI M CRUCIANI G PAGANO F BACCOLO M PODDI ER BOCCIOLONE L SABELLI MA MAGGI R RESTELLI C DANTONA A LOCATELLI MC PESSI A RAINA A CHIARI S GABRIELE A PITTELLI MR IACOBELLI P DOGLIOTTI L GORZEGNO G MUSSO P VEGNA G COCO G ALLETTI DG PICCIOTTO F LUCCHESE V EPIS A DIPALUMBO VS DRUDI G RAVAIOLI A ZAMPELLA D MORANDI MG GORGA G ZUCCHELLI C CARIELLO S GALLETTO L SUSSIO M MASSACESI L MASSACESI M CARLI A TUCCI E TAJANI E CORRADO G BUMMA S DURANDO A MASSOBRIO M SBERVEGLIERI M BIASIO M GUERCIO E JURA R DANESE S WIERDIS T FARNELLI C TARANTINO G GRASSI R REPETTI F ROCCHI B GRAMPA M ERCOLI A GRISO C SIGNORI E ZANINI L PRESTI M KLIMEK M URBANSKI K BISWAS A VIEGAS O KOCHLI O DREHER E FEY M BECK G LUDIN J BONNEFOI H KRAUER F BAUER J DELMORE G FURRER C LORENZ U THURLIMANN B LORENZ U BRONZ L SANNA P WYSS D GOLDHIRSCH A GYR T LEIDI L PASTORELLI G PAGANI O REY P HAILER U BENZ J KAYE SB REED NS SYMONDS RP ATKINSON RJ AXFORD AT RUSTIN G SECKL MJ GREEN JA SCOTT IV GUTHRIE D HARPER PG CALMAN F DOBBS HJ WEIR P CASSONI A LEDERMAN JA SOUHAMI RL BOZZINO J ADAB F REDMAN CWE SCOBLE JE PATERSON M DANIEL F COWLEY N WILLIAMS CJ SPOONER D HONG A MCILLMURRAY M HENDYIBBS P HALL V IVESON TJ WHITEHOUSE JMA GARRY R LAMONT A ROBINSON A TRASK CW CLUBB AW MURRELL D NEWMAN G WILKINS M GOLDTHORP WO ROBERTS JK RADSTONE DJ WHIPP MJ LEDERMANN JA PATER J BUYSE M OMURA G
Citation: Mkb. Parmar et al., ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER, Lancet, 352(9140), 1998, pp. 1571-1576
THE TREATMENT OF MERKEL CELL-CARCINOMA AND ITS ASSOCIATION WITH IMMUNOSUPPRESSION
Authors: PLUNKETT TA HARRIS AJ OGG CS MACDONALD DM HARPER PG
Citation: Ta. Plunkett et al., THE TREATMENT OF MERKEL CELL-CARCINOMA AND ITS ASSOCIATION WITH IMMUNOSUPPRESSION, British journal of dermatology, 139(2), 1998, pp. 345-346
A RANDOMIZED TRIAL COMPARING METHOTREXATE AND VINBLASTINE (MV) WITH CISPLATIN, METHOTREXATE AND VINBLASTINE (CMV) IN ADVANCED TRANSITIONAL-CELL CARCINOMA - RESULTS AND A REPORT ON PROGNOSTIC FACTORS IN A MEDICAL-RESEARCH-COUNCIL STUDY
Authors: MEAD GM RUSSELL M CLARK P HARLAND SJ HARPER PG COWAN R ROBERTS JT USCINSKA BM GRIFFITHS GO PARMAR MKB
Citation: Gm. Mead et al., A RANDOMIZED TRIAL COMPARING METHOTREXATE AND VINBLASTINE (MV) WITH CISPLATIN, METHOTREXATE AND VINBLASTINE (CMV) IN ADVANCED TRANSITIONAL-CELL CARCINOMA - RESULTS AND A REPORT ON PROGNOSTIC FACTORS IN A MEDICAL-RESEARCH-COUNCIL STUDY, British Journal of Cancer, 78(8), 1998, pp. 1067-1075
CHEMOTHERAPY FOR OVARIAN-CANCER - A CONSENSUS STATEMENT ON STANDARD PRACTICE
Authors: ADAMS M CALVERT AH CARMICHAEL J CLARK PI COLEMAN RE EARL HM GALLAGHER CJ GANESAN TS GORE ME GRAHAM JD HARPER PG JAYSON GC KAYE SB LEDERMANN JA OSBORNE RJ PERREN TJ POOLE CJ RADFORD JA RUSTIN GJS SLEVIN ML SMYTH JF THOMAS H WILKINSON PM
Citation: M. Adams et al., CHEMOTHERAPY FOR OVARIAN-CANCER - A CONSENSUS STATEMENT ON STANDARD PRACTICE, British Journal of Cancer, 78(11), 1998, pp. 1404-1406
5-DAY ORAL ETOPOSIDE TREATMENT FOR ADVANCED SMALL-CELL LUNG-CANCER - RANDOMIZED COMPARISON WITH INTRAVENOUS CHEMOTHERAPY
Authors: SOUHAMI RL SPIRO SG RUDD RM DEELVIRA MCR JAMES LE GOWER NH LAMONT A HARPER PG
Citation: Rl. Souhami et al., 5-DAY ORAL ETOPOSIDE TREATMENT FOR ADVANCED SMALL-CELL LUNG-CANCER - RANDOMIZED COMPARISON WITH INTRAVENOUS CHEMOTHERAPY, Journal of the National Cancer Institute, 89(8), 1997, pp. 577-580
A CLINIC SYSTEM TO IMPROVE PRESCHOOL VACCINATIONS IN A LOW SOCIOECONOMIC-STATUS POPULATION
Authors: HARPER PG MADLONKAY DJ LUXENBERG MG TEMPEST R
Citation: Pg. Harper et al., A CLINIC SYSTEM TO IMPROVE PRESCHOOL VACCINATIONS IN A LOW SOCIOECONOMIC-STATUS POPULATION, Archives of pediatrics & adolescent medicine, 151(12), 1997, pp. 1220-1223
ACTIVATED OXAZAPHOSPHORINES ARE TRANSPORTED PREDOMINANTLY BY ERYTHROCYTES
Authors: HIGHLEY MS SCHRIJVERS D VANOOSTEROM AT HARPER PG MOMERENCY G VANCAUWENBERGHE K MAES RAA DEBRUIJN EA EDELSTEIN MB
Citation: Ms. Highley et al., ACTIVATED OXAZAPHOSPHORINES ARE TRANSPORTED PREDOMINANTLY BY ERYTHROCYTES, Annals of oncology, 8(11), 1997, pp. 1139-1144
A PHASE-II STUDY OF IFOSFAMIDE AND BLEOMYCIN IN ADVANCED OR RECURRENTCERVICAL-CARCINOMA
Authors: HIGHLEY MS SAMANDAS N ZIRAS N MORGAN MM HILL ME STEIN R BARKER S COLEMAN RE BLAKE PR MORRIS D SLEVIN ML WILTSHAW E HARPER PG
Citation: Ms. Highley et al., A PHASE-II STUDY OF IFOSFAMIDE AND BLEOMYCIN IN ADVANCED OR RECURRENTCERVICAL-CARCINOMA, International journal of gynecological cancer, 6(4), 1996, pp. 323-327
RANDOMIZED TRIAL ASSESSING THE ADDITION OF INTERFERON ALPHA-2A TO FLUOROURACIL AND LEUCOVORIN IN ADVANCED COLORECTAL-CANCER
Authors: SEYMOUR MT SLEVIN ML KERR DJ CUNNINGHAM D JAMES RD LEDERMANN JA PERREN TJ MCADAM WAF HARPER PG NEOPTOLEMOS JP NICHOLSON M DUFFY AM STEPHENS RJ STENNING SP TAYLOR I
Citation: Mt. Seymour et al., RANDOMIZED TRIAL ASSESSING THE ADDITION OF INTERFERON ALPHA-2A TO FLUOROURACIL AND LEUCOVORIN IN ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 14(8), 1996, pp. 2280-2288
PARTITIONING OF IFOSFAMIDE AND ITS METABOLITES BETWEEN RED-BLOOD-CELLS AND PLASMA
Authors: MOMERENCY G VANCAUWENBERGHE K HIGHLEY MS HARPER PG VANOOSTEROM AT DEBRUIJN EA
Citation: G. Momerency et al., PARTITIONING OF IFOSFAMIDE AND ITS METABOLITES BETWEEN RED-BLOOD-CELLS AND PLASMA, Journal of pharmaceutical sciences, 85(3), 1996, pp. 262-265
PREFERENTIAL LOCATION OF CIRCULATING ACTIVATED CYCLOPHOSPHAMIDE WITHIN THE ERYTHROCYTE
Authors: HIGHLEY MS HARPER PG SLEE PHTJ DEBRUIJN EA
Citation: Ms. Highley et al., PREFERENTIAL LOCATION OF CIRCULATING ACTIVATED CYCLOPHOSPHAMIDE WITHIN THE ERYTHROCYTE, International journal of cancer, 65(5), 1996, pp. 711-712
RETROSPECTIVE ANALYSIS OF 31 UNSELECTED CONSECUTIVE ELDERLY PATIENTS WITH HIGH-GRADE
Authors: UNDERHILL C CLARK J BOWCOCK SJ COWAN S OFFERMAN EL HARPER PG RASSAM SMB
Citation: C. Underhill et al., RETROSPECTIVE ANALYSIS OF 31 UNSELECTED CONSECUTIVE ELDERLY PATIENTS WITH HIGH-GRADE, British Journal of Haematology, 93, 1996, pp. 287-287
A RANDOMIZED TRIAL OF LOW-DOSE HIGH-FREQUENCY CHEMOTHERAPY AS PALLIATIVE TREATMENT OF POOR-PROGNOSIS SMALL-CELL LUNG-CANCER - A CANCER-RESEARCH CAMPAIGN TRIAL/
Authors: JAMES LE GOWER NH RUDD RM SPIRO SG HARPER PG TRASK CW PATRIDGE M DEELVIRA MCR SOUHAMI RL
Citation: Le. James et al., A RANDOMIZED TRIAL OF LOW-DOSE HIGH-FREQUENCY CHEMOTHERAPY AS PALLIATIVE TREATMENT OF POOR-PROGNOSIS SMALL-CELL LUNG-CANCER - A CANCER-RESEARCH CAMPAIGN TRIAL/, British Journal of Cancer, 73(12), 1996, pp. 1563-1568
LITHIUM GAMMOLINOLENATE (LIGLA) - A NOVEL OUTPATIENT TREATMENT FOR NONRESECTABLE PANCREATIC-CARCINOMA (PC)
Authors: UNDERHILL CR HARPER PG HIGHLEY MS AHEM J BARKER SC WRIGHT CJ AHMED A HOUSTON SJ MILES DW LARVIN M MASON RC
Citation: Cr. Underhill et al., LITHIUM GAMMOLINOLENATE (LIGLA) - A NOVEL OUTPATIENT TREATMENT FOR NONRESECTABLE PANCREATIC-CARCINOMA (PC), European journal of cancer, 31A, 1995, pp. 564-564
UPTAKE OF IFOSFAMIDE (IF) AND ITS METABOLITES BY ERYTHROCYTES (E)
Authors: HIGHLEY MS MOMERENCY G VANCAUWENBERGHE K VANOOSTEROM AT SCHRYVERS D DEBRUIJN EA MAES RA HARPER PG
Citation: Ms. Highley et al., UPTAKE OF IFOSFAMIDE (IF) AND ITS METABOLITES BY ERYTHROCYTES (E), European journal of cancer, 31A, 1995, pp. 942-942
ERYTHROCYTES AND THE DISTRIBUTION OF MITOMYCIN-C (MMC)
Authors: HIGHLEY MS PATTYN G LAMBRECHTS H DEBRUIJN EA VANOOSTEROM AT HARPER PG
Citation: Ms. Highley et al., ERYTHROCYTES AND THE DISTRIBUTION OF MITOMYCIN-C (MMC), European journal of cancer, 31A, 1995, pp. 969-969
TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA
Authors: CUNNINGHAM D ZALCBERG JR RATH U OLVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G AZAB M SEYMOUR L LOWERY K ACKLAND SP BASSER RL CLARKE SJ GOLDSTEIN D GREEN MD GRYGIEL JJ MCKENDRICK JJ MILLWARD MJ OLVER IN TATTERSALL MHN THOMSON DB JAKESZ R BUSET M TUENI EA VANCUTSEM EJD BAUER J BESKA F ADENIS A BRUNET R FRANCOIS E PAILLOT B ROUGIER P FINK UFW KNUTH KRA KOENIG HJ BOHME MWJ WANDER HE AMADORI D FRASSINETI L COCCONI G PASSALACQUA R FRIGERIO F BARNI S LUPORINI G LABIANCA R MARINI G ZANIBONI A KLEPP O TVEIT KM WIST E CANDEIAS OFR GOUVEIA JGP MARQUES JCN OLIVEIRA JML CAVALLI F DELMORE GD GOEDHALS L VOROBIOF DA ESTEVE AAI AGUILAR EA TORRES AA RUIPEREZ AC RUBIO ED SUREDA BM MANGA GP ALFONSO PG GUSTAVSSON B JEPPSON B MALMBERG M STARKHAMMAR H SVENSSON JH KEIZER HJ SCHORNAGEL JH OBRIEN M HARPER PG KERR DJ SCARFFE JH TYRELL CJ
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA, European journal of cancer, 31A(12), 1995, pp. 1945-1954
A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL ASSESSINGTHE TOLERABILITY AND EFFICACY OF GLUTATHIONE AS AN ADJUVANT TO ESCALATING DOSES OF CISPLATIN IN THE TREATMENT OF ADVANCED OVARIAN-CANCER
Authors: PARNIS FX COLEMAN RE HARPER PG PICKERING D TOPHAM C WHITTINGTON JR TEDESCHI M
Citation: Fx. Parnis et al., A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL ASSESSINGTHE TOLERABILITY AND EFFICACY OF GLUTATHIONE AS AN ADJUVANT TO ESCALATING DOSES OF CISPLATIN IN THE TREATMENT OF ADVANCED OVARIAN-CANCER, European journal of cancer, 31A(10), 1995, pp. 1721-1721
ASSESSMENT OF QUALITY-OF-LIFE USING A DAILY DIARY CARD IN A RANDOMIZED TRIAL OF CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER
Authors: GOWER NH RUDD RM DEELVIRA MCR SPIRO SG JAMES LE HARPER PG SOUHAMI RL
Citation: Nh. Gower et al., ASSESSMENT OF QUALITY-OF-LIFE USING A DAILY DIARY CARD IN A RANDOMIZED TRIAL OF CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, Annals of oncology, 6(6), 1995, pp. 575-580
GENDER AFFECTS DOXORUBICIN PHARMACOKINETICS IN PATIENTS WITH NORMAL LIVER BIOCHEMISTRY
Authors: DOBBS NA TWELVES CJ GILLIES H JAMES CA HARPER PG RUBENS RD
Citation: Na. Dobbs et al., GENDER AFFECTS DOXORUBICIN PHARMACOKINETICS IN PATIENTS WITH NORMAL LIVER BIOCHEMISTRY, Cancer chemotherapy and pharmacology, 36(6), 1995, pp. 473-476
FORMATION OF CHLOROETHYLAMINE AND 1,3-OXAZOLIDINE-2-ONE FOLLOWING IFOSFAMIDE ADMINISTRATION IN HUMANS
Authors: HIGHLEY MS MOMERENCY G VANCAUWENBERGHE K VANOOSTEROM AT DEBRUIJN EA MAES RAA BLAKE P MANSI J HARPER PG
Citation: Ms. Highley et al., FORMATION OF CHLOROETHYLAMINE AND 1,3-OXAZOLIDINE-2-ONE FOLLOWING IFOSFAMIDE ADMINISTRATION IN HUMANS, Drug metabolism and disposition, 23(3), 1995, pp. 433-437
PHASE-II TRIAL OF TEMOZOLOMIDE IN LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: WOLL PJ CROWTHER D JOHNSON PWM SOUKOP M HARPER PG HARRIS M BRAMPTON MH NEWLANDS ES
Citation: Pj. Woll et al., PHASE-II TRIAL OF TEMOZOLOMIDE IN LOW-GRADE NON-HODGKINS-LYMPHOMA, British Journal of Cancer, 72(1), 1995, pp. 183-184
DETERMINATION OF IPHOSPHAMIDE AND 7 METABOLITES IN BLOOD-PLASMA, AS STABLE TRIFLUOROACETYL DERIVATIVES, BY ELECTRON-CAPTURE CHEMICAL-IONIZATION GC-MS
Authors: MOMERENCY G VANCAUWENBERGHE K DEBRUIJN EA VANOOSTEROM AT HIGHLEY MS HARPER PG
Citation: G. Momerency et al., DETERMINATION OF IPHOSPHAMIDE AND 7 METABOLITES IN BLOOD-PLASMA, AS STABLE TRIFLUOROACETYL DERIVATIVES, BY ELECTRON-CAPTURE CHEMICAL-IONIZATION GC-MS, HRC. Journal of high resolution chromatography, 17(9), 1994, pp. 655-661
HEALTH PROMOTION COUNSELING IN RESIDENCY TRAINING
Authors: MADLONKAY DJ HARPER PG REIF CJ
Citation: Dj. Madlonkay et al., HEALTH PROMOTION COUNSELING IN RESIDENCY TRAINING, Journal of general internal medicine, 9(8), 1994, pp. 465-467
Risultati: 1-25 | 26-32